Broncus Holding Corporation logo

Broncus Holding Corporation (BRNHF)

Market Open
12 Jun, 20:00
OTC PINK OTC PINK
$
0. 08
0
0%
$
42.13M Market Cap
- P/E Ratio
- Div Yield
10,000 Volume
- Eps
$ 0.08
Previous Close
Add Transaction
Day Range
0.08 0.08
Year Range
0.08 0.08
Want to track BRNHF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BRNHF trading today higher at $0.08, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, BRNHF stock gained 0%.
BRNHF is not paying dividends to its shareholders.
The last earnings report, released on Apr 01, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

BRNHF Chart

People also search for

NDT Pharmaceuticals Inc.
$ 0.53
-6.1883%
VicapSys Life Sciences Inc.
$ 1.46
0%
Medigene AG
$ 2.59
0%
Quantumzyme Corp.
$ 0.8
+33.3333%
Positive Physicians Holdings, Inc.
$ 8.5
0%

Broncus Holding Corporation (BRNHF) FAQ

What is the stock price today?

The current price is $0.08.

On which exchange is it traded?

Broncus Holding Corporation is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is BRNHF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 42.13M.

Has Broncus Holding Corporation ever had a stock split?

No, there has never been a stock split.

Broncus Holding Corporation Profile

Biotechnology Industry
Healthcare Sector
Hong Xu CEO
OTC PINK Exchange
KYG1609T1022 ISIN
CN Country
200 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Broncus Holding Corporation is a pioneering medical device company dedicated to advancing the field of interventional pulmonology. Established in 2012 and headquartered in Hangzhou, China, the company engages in the development and distribution of innovative products across Mainland China, the European Union, the United States, and other international markets. Its portfolio spans navigation and treatment products for lung diseases, as well as diagnostic tools that cater to the needs of the pulmonology community. By focusing on breakthrough technologies, Broncus aims to improve patient outcomes and enhance the precision and effectiveness of lung disease management.

Products and Services

  • LungPoint Virtual Bronchoscopic Navigation: A sophisticated computer-assisted image-based navigation software system designed to enhance the accuracy of lung navigations and interventions.
  • LungPoint Plus/Archimedes Lite: This system offers real-time navigation within the airways, facilitating lung biopsies and other pulmonary procedures with greater precision.
  • LungPro: A virtual bronchoscopic navigation tool providing three-dimensional, real-time guided transbronchial needle aspiration and proprietary parenchymal navigation, aimed at improving diagnostic yield and procedural safety.
  • InterVapor: A bronchoscopic thermal vapor ablation system targeted at diseased hyper-inflated lung segments to ablate them effectively, offering a non-surgical option for lung volume reduction.
  • RF Generator + RF Ablation Catheter: This radiofrequency ablation system, used in conjunction with a disposable lung radiofrequency ablation catheter, targets lung cancer by applying heat to destroy cancer cells.
  • H-Marker: A pulmonary surgical marker that assists surgeons in precisely locating lung nodules during surgical pneumonectomy, enhancing surgical accuracy.
  • BioStarNeedle: A single-use ultrasound-guided aspiration needle designed for the retrieval of tissue samples, facilitating accurate diagnoses of lung conditions.
  • FleXNeedle: A versatile biopsy needle that can be used for multiple purposes, including lung biopsies, providing flexibility and efficiency in pulmonary procedures.
  • Archimedes Sheath: A sterile, single-use flexible tube that offers a working channel during bronchoscopic procedures, improving access and maneuverability.
  • Archimedes Dilation Balloon: A balloon catheter used to dilate target lung tissue of the bronchial tree, aiding in the treatment of stenoses and facilitating other interventional procedures.
  • Steerable Sheath: This device features an adjustment handle and a working channel, enabling precise steering and positioning during bronchoscopic interventions, thus enhancing procedural outcomes.

Contact Information

Address: Room 801, Building 8
Phone: +852 3900 0888